Latest Insider Transactions at Trans Medics Group, Inc. (TMDX)
This section provides a real-time view of insider transactions for Trans Medics Group, Inc. (TMDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TransMedics Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TransMedics Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 31
2023
|
Miriam Provost VP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
2,708
-10.29%
|
$178,728
$66.52 P/Share
|
|
Aug 31
2023
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,480
+9.81%
|
$109,600
$20.84 P/Share
|
|
Aug 29
2023
|
David Weill |
BUY
Open market or private purchase
|
Direct |
2,500
+15.44%
|
$155,000
$62.0 P/Share
|
|
Aug 01
2023
|
Anil P. Ranganath |
BUY
Grant, award, or other acquisition
|
Direct |
9,512
+50.0%
|
-
|
|
Aug 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.46%
|
$690,000
$92.86 P/Share
|
|
Jul 18
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.81%
|
$475,000
$95.37 P/Share
|
|
Jul 18
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.75%
|
$135,000
$27.3 P/Share
|
|
Jul 13
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Indirect |
2,225
-13.09%
|
$200,250
$90.02 P/Share
|
|
Jul 13
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,974
-17.14%
|
$267,660
$90.05 P/Share
|
|
Jul 13
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,974
+14.63%
|
$47,584
$16.14 P/Share
|
|
Jul 03
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.45%
|
$615,000
$82.67 P/Share
|
|
Jun 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.67%
|
$532,500
$71.83 P/Share
|
|
May 25
2023
|
Edwin M Kania Jr |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+0.46%
|
-
|
|
May 25
2023
|
Stephanie Lovell |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+50.0%
|
-
|
|
May 25
2023
|
David Weill |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+9.63%
|
-
|
|
May 25
2023
|
Thomas James Gunderson |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+50.0%
|
-
|
|
May 25
2023
|
Edward M Basile |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+7.14%
|
-
|
|
May 25
2023
|
Merilee Raines |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+50.0%
|
-
|
|
May 25
2023
|
James R Tobin |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+50.0%
|
-
|
|
May 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.44%
|
$585,000
$78.87 P/Share
|
|
May 01
2023
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-21.02%
|
$395,000
$79.05 P/Share
|
|
May 01
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.37%
|
$80,000
$16.14 P/Share
|
|
Apr 21
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Indirect |
2,775
-14.03%
|
$249,750
$90.04 P/Share
|
|
Apr 21
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,026
-17.55%
|
$1,046,262
$87.18 P/Share
|
|
Apr 21
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,026
+18.11%
|
$192,416
$16.14 P/Share
|
|
Apr 03
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.44%
|
$562,500
$75.07 P/Share
|
|
Mar 10
2023
|
Waleed H Hassanein President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
193,074
+25.16%
|
$386,148
$2.21 P/Share
|
|
Mar 01
2023
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
3,500
-19.65%
|
$280,000
$80.1 P/Share
|
|
Mar 01
2023
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-21.02%
|
$395,000
$79.51 P/Share
|
|
Mar 01
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.37%
|
$80,000
$16.14 P/Share
|
|
Mar 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.97%
|
$600,000
$80.59 P/Share
|
|
Feb 28
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-20.18%
|
$400,000
$80.06 P/Share
|
|
Feb 28
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-41.03%
|
$800,000
$80.15 P/Share
|
|
Feb 28
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+29.09%
|
$160,000
$16.14 P/Share
|
|
Feb 28
2023
|
Edwin M Kania Jr |
BUY
Other acquisition or disposition
|
Direct |
242,477
+37.53%
|
$19,155,683
$79.76 P/Share
|
|
Feb 27
2023
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
5,000
-7.9%
|
$385,000
$77.92 P/Share
|
|
Feb 27
2023
|
David Weill |
SELL
Open market or private sale
|
Direct |
5,934
-19.62%
|
$456,918
$77.08 P/Share
|
|
Feb 27
2023
|
David Weill |
BUY
Exercise of conversion of derivative security
|
Direct |
5,934
+27.14%
|
$83,076
$14.2 P/Share
|
|
Feb 23
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
35,930
-15.68%
|
$2,586,960
$72.84 P/Share
|
|
Feb 23
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,930
+23.91%
|
$574,880
$16.07 P/Share
|
|
Feb 23
2023
|
James R Tobin |
SELL
Open market or private sale
|
Indirect |
10,000
-3.94%
|
$750,000
$75.13 P/Share
|
|
Feb 23
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
37,827
-1.83%
|
$2,723,544
$72.95 P/Share
|
|
Feb 20
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,075
+41.03%
|
-
|
|
Feb 20
2023
|
Waleed H Hassanein President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,332
+8.05%
|
-
|
|
Feb 20
2023
|
Nicholas Corcoran |
BUY
Grant, award, or other acquisition
|
Direct |
12,886
+50.0%
|
-
|
|
Feb 20
2023
|
Laura Damme VP, Clinical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
5,685
+50.0%
|
-
|
|
Feb 20
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,075
+47.63%
|
-
|
|
Feb 20
2023
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
5,685
+21.43%
|
-
|
|
Feb 14
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,070
-75.79%
|
$284,900
$70.15 P/Share
|
|
Feb 14
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,070
+43.11%
|
$65,120
$16.0 P/Share
|